<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2336">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04270383</url>
  </required_header>
  <id_info>
    <org_study_id>BCH Lung 012</org_study_id>
    <nct_id>NCT04270383</nct_id>
  </id_info>
  <brief_title>Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children</brief_title>
  <official_title>A Multicenter Observational Study About the Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Capital Institute of Pediatrics, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Xiamen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangzhou Women and Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Guangxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital Of Guizhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hainan People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Hebei Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Women and Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changchun Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiangxi Province Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanxi Provincial Maternity and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xian Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Medical University Second Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kunming Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital of Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to clarify the clinical characteristics, risk factors and long-term&#xD;
      prognosis of children with 2019-nCoV infection in China.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As of February 10th, 2020, more than 40,000 human have been confirmed infected with a novel&#xD;
      coronavirus (2019-nCoV) in China, with at least 800 reported deaths. Additional cases have&#xD;
      been confirmed in multiple countries, and some are reported in children. Patients with&#xD;
      confirmed 2019-nCoV infection have reported respiratory illness with fever, cough, et al.&#xD;
      Some are asymptomatic carriers. However, there are relatively few diagnosed cases of&#xD;
      children, and the long-term prognosis is unknown. Therefore, a multicenter observational&#xD;
      study is needed to better understand the clinical characteristics of 2019-nCoV infection in&#xD;
      children.&#xD;
&#xD;
      This observational study will last from February to December 2020. The patients enrolled were&#xD;
      diagnosed with 2019-nCoV infection or 2019-nCoV pneumonia by Beijing Children's Hospital and&#xD;
      other members of Chinese National Clinical Research Center for Respiratory Diseases in&#xD;
      2019-2020. At the same time, children hospitalized with pneumonia other than 2019-nCoV&#xD;
      pneumonia during the same period are classified as the control group by 3~5:1 matching for&#xD;
      age and sex to the 2019-nCoV group. After guardians signing the informed consent forms, all&#xD;
      the participants' clinical data, laboratory examination results, image data and also the&#xD;
      follow-up information after six months of their treatment will be collected.&#xD;
&#xD;
      The trial will be completed in 10 months, with subjects recruited from the hospitals that in&#xD;
      partnership with clinical research collaboration of National Clinical Research Center for&#xD;
      Respiratory Diseases.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 15, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The cure rate of 2019-nCoV.</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The improvement rate of 2019-nCoV.</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The incidence of long-term adverse outcomes.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of fever</measure>
    <time_frame>2 weeks</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of respiratory symptoms</measure>
    <time_frame>2 weeks</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>2 weeks</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participant(s) need intensive care</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participant(s) with acute respiratory distress syndrome</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participant(s) with extra-pulmonary complications, including shock, renal failure, multiple organ failure, hemophagocytosis syndrome, et al.</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participant(s) who died during the trial</measure>
    <time_frame>10 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>2019-nCoV</condition>
  <arm_group>
    <arm_group_label>2019-nCoV infection group</arm_group_label>
    <description>Children hospitalized with direct laboratory confirmed of novel coronavirus with or without pneumonia are classified as the 2019-nCoV infection group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Children hospitalized with pneumonia other than the novel coronavirus pneumonia during the same hospitalization period as 2019-nCoV infection group are classified as the control group.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are aged 1day to 18 years, and diagnosed with 2019-nCoV infection/pneumonia or&#xD;
        pneumonia other than novel coronavirus hospitalized in the same period in China.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        1. For the 2019-nCoV infection group&#xD;
&#xD;
             Inclusion Criteria:&#xD;
&#xD;
             Diagnosed with 2019-nCoV infection (with direct laboratory evidence).&#xD;
&#xD;
               1. Respiratory or blood samples tested positive for novel coronavirus nucleic acid&#xD;
                  with RT-PCR.&#xD;
&#xD;
               2. Gene sequencing of respiratory or blood samples show highly homologous with known&#xD;
                  novel coronaviruses.&#xD;
&#xD;
             Exclusion Criteria:&#xD;
&#xD;
             Subjects will be excluded if the children or their parents disagree to conduct this&#xD;
             study.&#xD;
&#xD;
          2. For the control group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosed with pneumonia, and excepted of novel coronavirus infection.&#xD;
&#xD;
          2. The hospitalization time is the same as that of novel coronavirus pneumonia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Subject will be excluded if she or he has one of the following:&#xD;
&#xD;
          1. First diagnosis is not pneumonia.&#xD;
&#xD;
          2. Any one of the novel coronavirus laboratory test results show positive.&#xD;
&#xD;
          3. Children or their parents disagree to conduct this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kunling Shen, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Children's Hospital of Capital Medical University, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tianyou Wang, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Children's Hospital of Capital Medical University, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Baoping Xu, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Children's Hospital of Capital Medical University, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Baoping Xu, MD,PhD</last_name>
    <phone>861059616308</phone>
    <email>xubaopingbch@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kunling Shen, MD,PhD</last_name>
    <email>kunlingshen1717@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Children's Hospital,</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Lina Wang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 11, 2020</study_first_submitted>
  <study_first_submitted_qc>February 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>February 14, 2020</last_update_submitted>
  <last_update_submitted_qc>February 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Children's Hospital</investigator_affiliation>
    <investigator_full_name>Kunling Shen</investigator_full_name>
    <investigator_title>Director of National Clinical Research Center for Respiratory Diseases, China</investigator_title>
  </responsible_party>
  <keyword>2019-nCoV infection</keyword>
  <keyword>2019-nCoV pneumonia</keyword>
  <keyword>Children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

